KZIA

KAZIA THERAPEUTICS LTD

Healthcare · Biotechnology

$262.23 sample

+0.97 (+0.37%) 1D

Market cap

$949.5B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-08

Alerts

8

Price$262.23 +4.62% 3M daily closessample

278.46249.94

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: 10% owner
Sep 21INSInsider sell: EVP, Operations
Sep 14INSInsider sell: Director
Sep 08SECForm 144 filed
Aug 28INSInsider sell: Director
Aug 21INSInsider sell: Chief Executive Officer
Aug 13SECForm 144 filed
Aug 10INSInsider sell: Director

Sign up to see the real KZIA record →

Company facts

SEC EDGAR registration

Name: KAZIA THERAPEUTICS LTD
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -51sample, -100 to +100
Reporting currency: USD

Who is positioning in KZIA

sample

Insiders: 8 insider transactions over 90 days, net selling, $152.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 6 funds hold $23.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$48.4B +16.9% y/y

Q4 2024Q3 2026

Inventory$29.4B +13.3% y/y

Q4 2024Q3 2026

Accounts receivable$21.2B +11.4% y/y

Q4 2024Q3 2026

Total debt$57.5B +16.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $610.1B -1.0% 3M
Sample peer B: $158.3B +15.6% 3M
Sample peer C: $454.4B -8.6% 3M
Sample peer D: $821.8B +5.9% 3M
Sample peer E: $139.2B -0.9% 3M